Women’s Health Diagnostic Test Market Top Players Biomerieux SA, F. Hoffmann-LA Roche AG, Becton, Dickinson and Company, Siemens AG, Abbott Laboratories

In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in the U.S. This program is expected to create awareness of CVD related diseases among women and also help to improve lifestyle.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/971

In 2017, Mission Hope Cancer Center accredited by the National Accreditation Program for Breast Cancer Centers (NAPBC) joined Dignity Health Central Coast hospitals. In Mission Hope’s cancer care program, breast cancer examination services and facility is expected to be provided to women. Moreover, in 2017, Dignity Health installed 3D imaging technology - Mammography in the central coast. This technology helps in detection of breast cancer before symptomatic stage, which increases 98% survival rate. Thus, this program is expected to create more awareness and early detection of cancer, which in turn is expected to augment the growth of women’s health diagnostic test market.

In 2016, Aeon Clinical Labs launched a RUO women’s health panel test, which is developed by Thermo Fischer Scientific. This test is based on PCR that detects 34 different target include candidiasis, bacterial vaginosis, and sexual transmitted diseases such as gonorrhea, chlamydia, and some others. Aeon is further aiming to expand genetic assays for pharmacogenomics and hereditary cancer in the near future.

Most of the organization and foundations running breast cancer awareness program at local, state, and national level include National Breast Cancer foundation, World Health Organization, and National Institute of Health and Family Welfare (NIHFW), which is expected to fuel growth of women’s health diagnostic test market during the forecast period.

Furthermore, according to the Centers for Disease Control and Prevention (CDC), in 2015, around 3,978,497 new born were estimated, which supports the increasing pregnancy cases and demand for various gestation and fertility tests and treatments, which is one of the major factors expected to propel growth of women’s health diagnostic test market in the near future.

Some of the key players operating in the global women’s health diagnostic test market include Biomerieux SA, F. Hoffmann-LA Roche AG, Becton, Dickinson and Company, Siemens AG, Abbott Laboratories, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Inc., GE Healthcare, and Alere Inc.

Get Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/971

Women’s Health Diagnostic Test Market taxonomy:

By Application

Ovarian Cancer Test
Diagnostic Imaging Tests
Ovarian Cancer Tumor Marker Test
Others
Breast Cancer Test
Biopsies
Mammography
Breast Cancer Tumor Marker Test
Blood Chemistries and Blood Cell Count Test
Others
Osteoporosis Test
Bone Densitometry
In Vitro Blood Test
Cervical Cancer Test
PAP Smear
HPV Test
Pregnancy and Fertility Test
Lab-Based Test
Fertility Monitors
Pregnancy Testing and Ovulation Prediction Kits
Ultrasound Test
Breast Imaging
Obstetrics/ Gynecology Imaging
Prenatal Genetic Screening and Carrier Test
Cystic Fibrosis
Torch Infections
Down Syndrome and Edwards Syndrome
Others
Infectious Disease Test
MRSA Test
Hepatitis Test
Tuberculosis Test
Urinary Tract Infection Test
Others
Sexually Transmitted Disease (STD) Test
HIV Test
Chlamydia Trachomatis and Neisseria Gonorrhoeae Test
Others
By End-user Industry

Hospitals
Clinics
Diagnostic Laboratories
Others

Abhout US

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.